Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized EPO Treatment of Neonatal Anemia
NCT02075970Phase 2Completed
- Sponsor
- University of Iowa
- Start
- Jun 2014
- Primary completion
- Jun 2019
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in neonatal anemia, sponsored by University of Iowa. Started Jun 2014; status: completed.
02
Drugs
epoetin alfa
03
Conditions
neonatal anemia
Beyond the preview
Go deeper on NCT02075970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02075970.